Cite
MLA Citation
S.N. Gettinger et al.. “81: Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastases.” Lung cancer, vol. 87, n.d., pp. S32–. http://access.bl.uk/ark:/81055/vdc_100048591856.0x000001